Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell interactions. Previous studies showed an increase in HLA cl...

Full description

Saved in:
Bibliographic Details
Main Authors: Greta Garrido (Author), Ailem Rabasa (Author), Cristina Garrido (Author), Lisset Chao (Author), Federico Garrido (Author), Ángel M. García-Lora (Author), Belinda Sánchez-Ramírez (Author)
Format: Book
Published: Frontiers Media S.A., 2017-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items